Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oseltamivir resistance--disabling our influenza defenses.

Literature DB >> 16371626

Oseltamivir resistance--disabling our influenza defenses.

Anne Moscona¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2005 PMID： 16371626 DOI： 10.1056/NEJMp058291

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

120 in total

Review 1. Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors: Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal: Expert Rev Mol Med Date: 2010-04-29 Impact factor: 5.600

2. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

Authors: Elodie Ghedin; Jennifer Laplante; Jay DePasse; David E Wentworth; Roberto P Santos; Martha L Lepow; Joanne Porter; Kathleen Stellrecht; Xudong Lin; Darwin Operario; Sara Griesemer; Adam Fitch; Rebecca A Halpin; Timothy B Stockwell; David J Spiro; Edward C Holmes; Kirsten St George
Journal: J Infect Dis Date: 2011-01-15 Impact factor: 5.226

3. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

Authors: Gallen B Triana-Baltzer; Rebecca L Sanders; Maria Hedlund; Kellie A Jensen; Laura M Aschenbrenner; Jeffrey L Larson; Fang Fang
Journal: J Antimicrob Chemother Date: 2010-11-21 Impact factor: 5.790

10. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.

Authors: Deepak Gupta; Sheeba Varghese Gupta; Arik Dahan; Yasuhiro Tsume; John Hilfinger; Kyung-Dall Lee; Gordon L Amidon
Journal: Mol Pharm Date: 2013-01-04 Impact factor: 4.939

Oseltamivir resistance--disabling our influenza defenses.

Review 1. Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

2. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

3. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

4. The impact of prophylaxis of healthcare workers on influenza pandemic burden.

5. Stochastic model of an influenza epidemic with drug resistance.

6. The effect of population structure on the emergence of drug resistance during influenza pandemics.

7. Emergence of drug resistance: implications for antiviral control of pandemic influenza.

8. Management of drug resistance in the population: influenza as a case study.

9. 3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.

10. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.